Press "Enter" to skip to content

Alembic Pharma gets USFDA nod for erectile dysfunction drug

The approval from the United States Food and Drug Administration (USFDA) is for the company’s abbreviated new drug application (ANDA) for Tadalafil tablets USP, in the strengths of 2.5 mg, 5mg, 10mg and 20 mg, Alembic Pharmaceuticals said in a filing to BSE.

Original source: https://health.economictimes.indiatimes.com/news/pharma/alembic-pharma-gets-usfda-nod-for-erectile-dysfunction-drug/68594567?utm_source=RSS&utm_medium=ETRSS

Also Read:   Japan's AnGes begins Phase 2 clinical trials of DNA vaccine against Covid-19